Company news

Kissei Pharmaceutical Co., Ltd. news in 2026

Kissei Pharmaceutical Co., Ltd.'s news releases, calls and decks from 2026, newest first.

View company

Financial Briefing for the Second Quarter (Interim) of the Fiscal Year Ended March 31, 2027 (Fiscal 2026)

November 5, 2026

Notice Concerning the Results of the Acquisition of Treasury Shares through ToSTNeT-3

November 4, 2026

Supplementary Explanatory Materials on Financial Results for the Six Months Ended September 30, 2026

November 4, 2026

Notice Concerning the Purchase of Treasury Shares through ToSTNeT-3

November 4, 2026

Notice Concerning Status of Acquisition of Treasury Shares

November 4, 2026

Consolidated Financial Results for the Six Months Ended September 30, 2026 [Japanese GAAP]

November 4, 2026

Notice Concerning Revisions to Financial Results Forecast

October 29, 2026

Announcement for the Results Report by the Council of Pharmaceutical Affairs (Mdical Product Second Section) on TAVNEOS

October 21, 2026

Notice Concerning Status of Acquisition of Treasury Shares

October 5, 2026

Notice of Completion of Payment for Treasury Shares Disposal as Restricted Stock for Employee Shareholding Association and Partial

August 10, 2026

Consolidated Financial Results for the Three Months Ended June 30, 2026 [Japanese GAAP]

July 31, 2026

Notice Regarding Completion of Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers

July 23, 2026

Announcement for the Opnion by European Authorities on TAVNEOS

June 28, 2026

Notice Concerning Disposal of Treasury Shares as Restricted Stock for Members of the Board and Corporate Officers

June 23, 2026

Notice Concerning Status of Acquisition of Treasury Shares

June 3, 2026

Decks in 2026